{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:36:56Z","timestamp":1791815816365,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","award":["THV-F20-142"],"award-info":[{"award-number":["THV-F20-142"]}],"id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.acvd.2023.08.001","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:22:07Z","timestamp":1694550127000},"page":"506-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of patients with active cancer undergoing transcatheter aortic valve replacement"],"prefix":"10.1016","volume":"116","author":[{"given":"Antonin","family":"Trimaille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Marchandot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Reydel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Faucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Granier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung Anh","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bamba","family":"Diop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Jesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2023.08.001_bib0165","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ahj.2011.03.013","article-title":"Management and outcomes of severe aortic stenosis in cancer patients","volume":"161","author":"Yusuf","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2023.08.001_bib0170","first-page":"150","article-title":"The double jeopardy of aortic stenosis in cancer patients","volume":"4","author":"Kornowski","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.acvd.2023.08.001_bib0175","first-page":"180","article-title":"Malignant disease as a comorbidity in patients with severe aortic stenosis: clinical presentation, outcomes, and management","volume":"4","author":"Minamino-Muta","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.acvd.2023.08.001_bib0180","doi-asserted-by":"crossref","first-page":"e002533","DOI":"10.1161\/JAHA.115.002533","article-title":"Cancer and its association with the development of coronary artery calcification: an assessment from the multi-ethnic study of atherosclerosis","volume":"4","author":"Whitlock","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2023.08.001_bib0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIR.0b013e318282ab8f","article-title":"Executive summary: heart disease and stroke statistics\u00a0\u2013\u00a02013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2023.08.001_bib0190","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acvd.2023.08.001_bib0195","doi-asserted-by":"crossref","first-page":"e006929","DOI":"10.1161\/CIRCINTERVENTIONS.118.006929","article-title":"Length of stay and discharge disposition after transcatheter versus surgical aortic valve replacement in the United States","volume":"11","author":"Arora","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2023.08.001_bib0200","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.athoracsur.2017.11.014","article-title":"Cardiac surgery outcomes in patients with chronic lymphocytic leukemia","volume":"105","author":"Zhu","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.acvd.2023.08.001_bib0205","first-page":"438","article-title":"An update on the management and outcomes of cancer patients with severe aortic stenosis","volume":"94","author":"Schechter","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2023.08.001_bib0210","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12872-022-02651-4","article-title":"Mortality after transcatheter aortic valve replacement for aortic stenosis among patients with malignancy: a systematic review and meta-analysis","volume":"22","author":"Siddiqui","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.acvd.2023.08.001_bib0215","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2023.08.001_bib0220","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2023.08.001_bib0225","first-page":"105","article-title":"Favorable short-term and long-term outcomes among patients with prior history of malignancy undergoing transcatheter aortic valve implantation","volume":"30","author":"Berkovitch","year":"2018","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0230","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2020.03.038","article-title":"Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement","volume":"315","author":"Biancari","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0235","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.amjcard.2016.05.052","article-title":"Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer","volume":"118","author":"Watanabe","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0240","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcin.2018.10.026","article-title":"Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis","volume":"12","author":"Landes","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2023.08.001_bib0245","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/joic.12458","article-title":"Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement","volume":"31","author":"Mangner","year":"2018","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0250","doi-asserted-by":"crossref","first-page":"e0260439","DOI":"10.1371\/journal.pone.0260439","article-title":"Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement","volume":"16","author":"Trimaille","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2023.08.001_bib0255","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2023.08.001_bib0260","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0265","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0270","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2011.02.026","article-title":"Prevalence of comorbidities and associated cardiac diseases in patients with valve aortic stenosis. Potential implications for the decision-making process","volume":"159","author":"Faggiano","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0275","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaccao.2020.11.008","article-title":"Impact of cancer in patients undergoing transcatheter aortic valve replacement: a single-center study","volume":"2","author":"Lind","year":"2020","journal-title":"JACC Cardiooncol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2018.09.041","article-title":"Blood disorders in patients undergoing transcatheter aortic valve replacement: a review","volume":"12","author":"De Larochelliere","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2023.08.001_bib0285","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2018.08.2143","article-title":"Primary hemostatic disorders and late major bleeding after transcatheter aortic valve replacement","volume":"72","author":"Kibler","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0290","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1055\/s-0040-1713424","article-title":"Paradoxical increase of stroke in patients with defect of high molecular weight multimers of the von Willebrand factors following transcatheter aortic valve replacement","volume":"120","author":"Matsushita","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.08.001_bib0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2022.04.088","article-title":"P2Y(12) inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement","volume":"360","author":"Matsushita","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0300","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.jacc.2019.09.036","article-title":"P2Y(12) inhibition by clopidogrel increases periprocedural bleeds in patients undergoing transcatheter aortic valve replacement","volume":"74","author":"Matsushita","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2023.08.001_bib0305","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2023.08.001_bib0310","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2023.08.001_bib0315","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2023.08.001_bib0320","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213623001651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213623001651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:48:35Z","timestamp":1761745715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213623001651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1875213623001651"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2023.08.001","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of patients with active cancer undergoing transcatheter aortic valve replacement","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2023.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}